Our antibodies
Read more about our ROR1 bispecifc antibody and its MoA
Our technologies
Explore
We are changing the paradigm of cancer therapy with our immunotherapy technology.
Auto-regulation platform
NovalGen’s proprietary ground-breaking autoregulation technology platform enables the maximum efficacy to be unleashed from a therapy whilst ensuring a manageable safety profile by limiting life threatening toxicities.
Key capabilities
Novalgen is a fully integrated company capable of developing breakthrough therapies.